We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
Cap. Flow
+$144M
Cap. Flow %
3.24%
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6 years
Top 10 Avg Time Held Equity + Options
2.7 years
Top 20 Avg Time Held Equity + Options
3.7 years
Avg Time Held Equity only
4.6 years
Top 10 Avg Time Held Equity only
2.7 years
Top 20 Avg Time Held Equity only
3.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.84%
2 Technology 15.96%
3 Healthcare 9.75%
4 Financials 7.52%
5 Communication Services 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ARLO icon
3151
Arlo Technologies
ARLO
$1.34B
$770 ﹤0.01%
78
+24
+44% +$274
2022 Q4
9 quarters
FTDR icon
3152
Frontdoor
FTDR
$5.49B
$768 ﹤0.01%
20
+5
+33% +$255
2024 Q1
4 quarters
WVE icon
3153
Wave Life Sciences
WVE
$636M
$768 ﹤0.01%
95
– –
2023 Q1
8 quarters
KYMR icon
3154
Kymera Therapeutics
KYMR
$8.76B
$766 ﹤0.01%
28
+15
+115% +$547
2023 Q4
5 quarters
GPI icon
3155
Group 1 Automotive
GPI
$2.94B
$764 ﹤0.01%
2
+1
+100% +$438
2024 Q2
3 quarters
ARWR icon
3156
Arrowhead Research
ARWR
$8.12B
$752 ﹤0.01%
59
-1,074
-95% -$19.5K
2023 Q4
5 quarters
DMXF icon
3157
iShares ESG Advanced MSCI EAFE ETF
DMXF
$1.01B
$741 ﹤0.01%
11
-30
-73% -$2.03K
2024 Q4
1 quarter
OI icon
3158
O-I Glass
OI
$916M
$733 ﹤0.01%
64
-1,281
-95% -$14.6K
2016 Q4
33 quarters
CTLP icon
3159
DELISTED
Cantaloupe
CTLP
$732 ﹤0.01%
93
– –
2024 Q2
3 quarters
HMN icon
3160
Horace Mann Educators
HMN
$1.88B
$726 ﹤0.01%
17
– –
2021 Q1
16 quarters
CEROW icon
3161
DELISTED
CERo Therapeutics Warrants
CEROW
$725 ﹤0.01%
+50,000
New +$705
2025 Q1
0 quarters
ARKO icon
3162
ARKO Corp
ARKO
$463M
$723 ﹤0.01%
183
+58
+46% +$339
2024 Q2
3 quarters
KRT icon
3163
Karat Packaging
KRT
$1.1B
$718 ﹤0.01%
27
– –
2024 Q3
2 quarters
DDLS icon
3164
WisdomTree Dynamic International SmallCap Equity Fund
DDLS
$417M
$707 ﹤0.01%
+20
New +$708
2025 Q1
0 quarters
SPT icon
3165
Sprout Social
SPT
$690M
$704 ﹤0.01%
32
+3
+10% +$87
2021 Q3
14 quarters
SNCY icon
3166
DELISTED
Sun Country Airlines
SNCY
$702 ﹤0.01%
+57
New +$883
2025 Q1
0 quarters
OFLX icon
3167
Omega Flex
OFLX
$257M
$696 ﹤0.01%
20
+9
+82% +$349
2024 Q2
3 quarters
AFCG icon
3168
AFC Gamma
AFCG
$71M
$691 ﹤0.01%
124
– –
2022 Q3
10 quarters
NSSC icon
3169
Napco Security Technologies
NSSC
$1.29B
$691 ﹤0.01%
30
-51
-63% -$1.45K
2022 Q2
11 quarters
GPRO icon
3170
GoPro
GPRO
$235M
$689 ﹤0.01%
1,040
+1,000
+2,500% +$882
2016 Q4
33 quarters
KALU icon
3171
Kaiser Aluminum
KALU
$2.49B
$680 ﹤0.01%
11
-1
-8% -$70
2024 Q3
2 quarters
SHO icon
3172
Sunstone Hotel Investors
SHO
$2.29B
$680 ﹤0.01%
72
-39
-35% -$423
2016 Q4
33 quarters
ATRO icon
3173
Astronics
ATRO
$2.71B
$677 ﹤0.01%
34
– –
2023 Q1
8 quarters
LMAT icon
3174
LeMaitre Vascular
LMAT
$1.92B
$671 ﹤0.01%
8
-24
-75% -$2.23K
2022 Q2
11 quarters
EQBK icon
3175
Equity Bancshares
EQBK
$980M
$670 ﹤0.01%
17
– –
2023 Q1
8 quarters

Similar funds

Parallel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.

  • Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
  • Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
  • Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
  • Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
  • Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
  • Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.